Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0000756
UniProt IDP61962
Primary gene name(s)DCAF7
Synonym gene name(s)HAN11, WDR68
Protein nameDDB1- and CUL4-associated factor 7
Protein functionInvolved in craniofacial development. Acts upstream of the EDN1 pathway and is required for formation of the upper jaw equivalent, the palatoquadrate. The activity required for EDN1 pathway function differs between the first and second arches, By similarity. Associates with DIAPH1 and controls GLI1 transcriptional activity. Could be involved in normal and disease skin development. May function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex. {ECO:0000250, ECO:0000269|PubMed:16887337, ECO:0000269|PubMed:16949367}.
Subcellular locationCytoplasm. Nucleus. Note=Overexpression of DIAHP1 or active RHOA causes translocation from the nucleus to cytoplasm.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P61962
Gene Ontology
(Biological Process)
Complete annatation
multicellular organism development [GO:0007275];
protein ubiquitination [GO:0016567]
Gene Ontology
(Molecular Function)
Complete annatation
Gene Ontology
(Cellular Component)
Complete annatation
Cul4-RING E3 ubiquitin ligase complex [GO:0080008];
cytoplasm [GO:0005737];
nuclear matrix [GO:0016363];
nucleoplasm [GO:0005654];
protein complex [GO:0043234]
Protein-protein interaction115532
Phylogenetic treeP61962
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD30.08864843634575690.7868733442575650.854264571393072
AZA vs. DISU-0.1021617591234740.6858643157158690.968293316945822
AZA vs. IL70.06440156385002270.7372231613730820.999311006273513
AZA vs. SAHA0.2144161735976030.3796231548293320.743971255637779
DISU vs. CD3-0.2025254612928150.5777949608336880.692784062965877
DISU vs. IL70.1571973798333460.5319857148795360.844532924579719
DISU vs. SAHA0.3181474925160690.276217506767210.656087319856362
DMSO vs. AZA0.003869294444677480.981527640159471
DMSO vs. CD3-0.09560136836469250.7656258170865760.832189966407595
DMSO vs. DISU0.1042697201900970.6685847015722420.954184134825904
DMSO vs. IL70.06781277963015770.7054607639660380.939646666682909
DMSO vs. SAHA0.2041773510188040.3872278172486630.734353916097921
HIV vs. Mock in Activation0.2330806886237340.7082727175859860.999983755607037
HIV vs. Mock in Latency0.05764316574058740.7263091853455810.999834320637052
IL7 vs. CD3-0.0174789302249160.9568262092732020.974201428433629
SAHA vs. CD30.1016343200536250.7732193878700220.837941620537986
SAHA vs. IL70.1470608401624430.5472421978421610.761551780859743
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) FALSE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK -0.285876 0.0809368
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
0.903 0.886 0.781 0.847 0.921
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
221744_at 1.61 No upregulated in CD8+ cells
221745_at 1.64 No upregulated in CD8+ cells

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
not found